Answers are grounded in this paper and cite their sources.
CRISPR-Cas9 genome editing is widely used to modify cultured cell lines. However, its implementation is still challenging due to the complex and often costly multi-step process associated with this technique and the variability in genome editing efficiency across cell types, which often limits utility. This protocol describes pCRISPR-EASY, a plasmid for simplified cloning of single guide RNAs and its simultaneous introduction with CRISPR-Cas9 into cultured cells using a non-viral delivery system. We outline a step-by-step protocol for genome editing in RAW264.7 macrophages, a mouse macrophage cell line that can easily be adapted for use in other systems.
No takes yet. Share an insight, caveat, or question.
Hossain et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: